Skip to main content
Toggle navigation
Login
Search
Home
Tweets by ISTH 2022
Back
Favorite
Katherine Garlo
Senior Medical Director
Alexion, AstraZeneca Rare Disease
Presentation(s):
PB0793 - Preference for ravulizumab over eculizumab: a real-world patient preference and life impact study on the treatment of atypical hemolytic uremic syndrome
Monday, July 11, 2022
6:30 PM – 7:30 PM